The article discusses the growing obsession among global elites with extending human lifespan through biotechnology, highlighting a conversation between Chinese President Xi Jinping and Russian President Vladimir Putin in September 2025 where they speculated about potential immortality through organ transplants and scientific advancements. It traces this trend back to around 2010, when Silicon Valley entrepreneurs began showing interest in longevity research, leading to breakthroughs such as extending mouse lifespans through cellular reprogramming and testing substances like rapamycin. The piece also references the 'biohacker' movement and the 2014 TV series 'Silicon Valley,' which depicted anti-aging techniques. In 2019, the company Ambrosia started offering young blood transfusions as a treatment, reflecting the increasing commercialization of life extension technologies.
Bias read (Center): While the article touches on political figures (Xi Jinping and Putin), its focus is more on the broader implications of biotech advancements and their societal impact rather than partisan politics. The framing remains balanced, presenting both scientific progress and ethical concerns without overtly
Why factuality (85): The article references a conversation between Xi Jinping and Vladimir Putin regarding biotechnology and immortality, but this specific dialogue is not mentioned in the primary source document. The article also discusses advancements in longevity science and mentions Bryan Johnson and other figures,
Why objectivity (70): The article presents the topic with a somewhat sensational tone, using phrases like 'dream of buying eternal life' and 'delirium.' It frames the discussion around elite obsession with immortality, which may introduce a biased perspective rather than presenting a neutral analysis of the scientific de



